These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 26119202)
1. Combined Cisplatin-Based Chemoembolization and Radiation Therapy for Hepatocellular Carcinoma Invading the Main Portal Vein. Chung SR; Kim JH; Yoon HK; Ko GY; Gwon DI; Shin JH; Song HY; Ko HK; Yoon SM J Vasc Interv Radiol; 2015 Aug; 26(8):1130-8. PubMed ID: 26119202 [TBL] [Abstract][Full Text] [Related]
2. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438 [TBL] [Abstract][Full Text] [Related]
3. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. Kim GA; Shim JH; Yoon SM; Jung J; Kim JH; Ryu MH; Ryoo BY; Kang YK; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS J Vasc Interv Radiol; 2015 Mar; 26(3):320-9.e6. PubMed ID: 25612807 [TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein. Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561 [TBL] [Abstract][Full Text] [Related]
5. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681 [TBL] [Abstract][Full Text] [Related]
6. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545 [TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study. Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678 [TBL] [Abstract][Full Text] [Related]
8. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346 [TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors. Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. Chung JW; Park JH; Han JK; Choi BI; Han MC AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting. Zhang XB; Wang JH; Yan ZP; Qian S; Liu R Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871 [TBL] [Abstract][Full Text] [Related]
12. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739 [TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up. Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization for infiltrative hepatocellular carcinoma: clinical safety and efficacy and factors influencing patient survival. Han K; Kim JH; Yoon HM; Kim EJ; Gwon DI; Ko GY; Yoon HK; Ko HK Korean J Radiol; 2014; 15(4):464-71. PubMed ID: 25053906 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma. Lance C; McLennan G; Obuchowski N; Cheah G; Levitin A; Sands M; Spain J; Srinivas S; Shrikanthan S; Aucejo FN; Kim R; Menon KV J Vasc Interv Radiol; 2011 Dec; 22(12):1697-705. PubMed ID: 21983055 [TBL] [Abstract][Full Text] [Related]
16. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. Hou JZ; Zeng ZC; Zhang JY; Fan J; Zhou J; Zeng MS Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):362-8. PubMed ID: 22381903 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial. Yoon SM; Ryoo BY; Lee SJ; Kim JH; Shin JH; An JH; Lee HC; Lim YS JAMA Oncol; 2018 May; 4(5):661-669. PubMed ID: 29543938 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Chung GE; Lee JH; Kim HY; Hwang SY; Kim JS; Chung JW; Yoon JH; Lee HS; Kim YJ Radiology; 2011 Feb; 258(2):627-34. PubMed ID: 21273524 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma]. Wu DH; Chen LH Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921 [TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization as first-line therapy for hepatocellular carcinomas infeasible for ultrasound-guided radiofrequency ablation: a retrospective cohort study of 116 patients. Song YG; Shin SW; Cho SK; Choi D; Rhim H; Lee MW; Kim YS; Park KB; Park HS; Choo SW; Do YS; Choo IW; Hyun D Acta Radiol; 2015 Jan; 56(1):70-7. PubMed ID: 24518688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]